• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Document › Details

CovalX AG. (11/15/09). "Press Release: Try CovalX’s HM2 on the New ABI MALDI ToF ToF 5800".

	Region	Framingham, MA
	Country	United States (USA)
	Organisation	CovalX AG
	Group	CovalX (Group)
	Organisation 2	Applied Biosystems Inc. (ABI) [new since 7/08, planned merger with Invitrogen]
	Group	Life Technologies (Group)
	Product	HM2 high-mass system
	Product 2	AB Sciex TOF/TOF™ 5800 System

The latest generation of CovalX's High-Mass MALDI detection system, HM2, is available for demonstration in combination with the ABI MALDI ToF ToF 5800 in the demonstration laboratory of Applied Biosystems in Framingham, MA, USA.

The use of CovalX HM2 in conjonction with ABI MALDI ToF ToF 5800 allows detection of macromolecules up to 1200 kDa for the direct analysis of portein and protein-protein interactions. The characterization of Antibody/antigen interactions; protein complex stoechiometry; therapeutic PEG proteins and therapeutic protein aggregates are now possible with outstanding accuracy and sensitivity.

The demonstration of HM2 on the ABI MALDI ToF TOF 5800 is now available for our North American customers. For any information contact us at infona@covalx.com.

Record changed: 2011-11-25

More documents for CovalX (Group)

• [1] CovalX AG. (10/15/11). "Press Release: The USPTO Grants CovalX a New Patent for the Analysis of Drug Candidates Targeting Protein-Protein Interactions". Zürich....
• [2] CovalX AG. (8/23/11). "Press Release: KTI Grants CovalX a 300k EUR Research and Development Voucher". Zürich....
• [3] CovalX AG. (4/27/11). "Press Release: CovalX Opens a New Production Facility in the USA"....
• [4] CovalX AG. (2/16/11). "Press Release: The USPTO Grants CovalX a New Patent for the Analysis of Therapeutic Protein Aggregates in the USA". Zürich....
• [5] CovalX AG. (11/30/10). "Press Release: The European Patent Office Grants ETHZ and CovalX a New Patent for Protein Interaction Analysis by MALDI Mass Spectrometry". Zürich....
• [6] CovalX AG. (8/2/10). "Press Release: CovalX Equipment Demonstrates Benefits for MALDI Imaging"....
• [7] CovalX AG. (6/21/10). "Press Release: ETH Zürich Grants CovalX Worldwide Exclusive License for the Patent Covering New Cross-linking Molecules"....
• [8] Shimadzu Scientific Instruments, Inc.. (6/2/10). "Press Release: Shimadzu and CovalX Launch the AXIMA MegaTOF for Ultrahigh-mass Applications"....
• [9] Shimadzu Scientific Instruments, Inc.. (5/24/10). "Press Release: Shimadzu to Introduce New Technologies at ASMS 2010 Conference". Columbia, MD....
• [10] CovalX AG. (5/20/10). "Press Release: MegaTOF MALDI Mass Spectrometer. A New MALDI Instrument by Shimadzu and CovalX"....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.